BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17037267)

  • 1. Multiple comparisons and multiple contrasts in randomized dose-response trials--confidence interval oriented approaches.
    Hothorn LA
    J Biopharm Stat; 2006; 16(5):711-31. PubMed ID: 17037267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to deal with multiple treatment or dose groups in randomized clinical trials?
    Hothorn LA
    Fundam Clin Pharmacol; 2007 Apr; 21(2):137-54. PubMed ID: 17391286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the partitioning principle to adaptively design dose-response studies.
    Ling X; Hsu J
    J Biopharm Stat; 2006; 16(5):733-43. PubMed ID: 17037268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fallback tests in dose-response clinical trials.
    Dmitrienko A; Wiens B; Westfall P
    J Biopharm Stat; 2006; 16(5):745-55. PubMed ID: 17037269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptotic simultaneous confidence intervals for many-to-one comparisons of binary proportions in randomized clinical trials.
    Schaarschmidt F; Biesheuvel E; Hothorn LA
    J Biopharm Stat; 2009; 19(2):292-310. PubMed ID: 19212881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-parametric estimators of a monotonic dose-response curve and bootstrap confidence intervals.
    Dilleen M; Heimann G; Hirsch I
    Stat Med; 2003 Mar; 22(6):869-82. PubMed ID: 12627406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bootstrap-based test for establishing noninferiority in clinical trials.
    Chen M; Kianifard F; Dhar SK
    J Biopharm Stat; 2006 May; 16(3):357-63. PubMed ID: 16724490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the maximum safe dose: a multiple testing approach.
    Hothorn LA; Hauschke D
    J Biopharm Stat; 2000 Feb; 10(1):15-30. PubMed ID: 10709798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothesis testing and Bayesian estimation using a sigmoid Emax model applied to sparse dose-response designs.
    Thomas N
    J Biopharm Stat; 2006; 16(5):657-77. PubMed ID: 17037264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive dose-finding: Proof of concept with type I error control.
    Miller F
    Biom J; 2010 Oct; 52(5):577-89. PubMed ID: 20976691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple testing of noninferiority hypotheses in active controlled trials.
    Hung HM; Wang SJ
    J Biopharm Stat; 2004 May; 14(2):327-35. PubMed ID: 15206530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y; Chen WJ
    J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
    Kaul S; Diamond GA
    Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ABC of non-inferiority margin setting from indirect comparisons.
    Julious SA
    Pharm Stat; 2011; 10(5):448-53. PubMed ID: 21928354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness inferences from bootstrap quadrant confidence levels: three degrees of dominance.
    Obenchain RL; Robinson RL; Swindle RW
    J Biopharm Stat; 2005; 15(3):419-36. PubMed ID: 15920889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing for interaction in studies of noninferiority.
    Wiens BL; Heyse JF
    J Biopharm Stat; 2003 Feb; 13(1):103-15. PubMed ID: 12635906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.